is tirzepatide fda approved for weight loss Semaglutide vs. Tirzepatide: Which Treatment Right You? Choosing between FDA approval for Zepbound (tirzepatide)

GLP-1 receptor agonists (semaglutide, liraglutide, dulaglutide) and the GIP/GLP-1 dual agonist tirzepatide are supported by STEP (semaglutide, NEJM 2021), SURMOUNT (tirzepatide, NEJM 2022), and SURMOUNT-OSA (tirzepatide for obstructive sleep apnea, NEJM 2024)

You might begin to notice some changes, like feeling less hungry, within the first week

While injectable GLP-1 medications generally have no direct pharmacokinetic interaction with levothyroxine, there are important considerations regarding oral semaglutide and indirect effects that warrant attention

These observations are usually mild and manageable in research settings but they highlight the importance of monitoring and adjusting research protocols as needed